Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1950 1
1952 1
1953 1
1954 1
1955 1
1957 2
1958 1
1960 3
1961 9
1962 6
1963 16
1964 15
1965 10
1966 22
1967 13
1968 16
1969 17
1970 35
1971 24
1972 33
1973 23
1974 51
1975 31
1976 24
1977 32
1978 56
1979 39
1980 64
1981 85
1982 65
1983 100
1984 97
1985 101
1986 128
1987 101
1988 135
1989 153
1990 133
1991 144
1992 162
1993 151
1994 188
1995 182
1996 166
1997 183
1998 212
1999 243
2000 245
2001 244
2002 224
2003 221
2004 236
2005 272
2006 260
2007 257
2008 249
2009 289
2010 299
2011 346
2012 354
2013 326
2014 312
2015 330
2016 334
2017 345
2018 350
2019 351
2020 444
2021 511
2022 263
Text availability
Article attribute
Article type
Publication date

Search Results

9,527 results
Results by year
Filters applied: . Clear all
Page 1
Reply.
Matsumoto K, Jin Z, Homma S, Elkind MSV, Schwartz JE, Rundek T, Mannina C, Ito K, Sacco RL, Di Tullio MR. Matsumoto K, et al. J Hypertens. 2021 Jun 1;39(6):1261-1262. doi: 10.1097/HJH.0000000000002825. J Hypertens. 2021. PMID: 33967220 No abstract available.
The monitoring of vancomycin: a systematic review and meta-analyses of area under the concentration-time curve-guided dosing and trough-guided dosing.
Tsutsuura M, Moriyama H, Kojima N, Mizukami Y, Tashiro S, Osa S, Enoki Y, Taguchi K, Oda K, Fujii S, Takahashi Y, Hamada Y, Kimura T, Takesue Y, Matsumoto K. Tsutsuura M, et al. Among authors: matsumoto k. BMC Infect Dis. 2021 Feb 6;21(1):153. doi: 10.1186/s12879-021-05858-6. BMC Infect Dis. 2021. PMID: 33549035 Free PMC article.
Therapeutic options for CTLA-4 insufficiency.
Egg D, Rump IC, Mitsuiki N, Rojas-Restrepo J, Maccari ME, Schwab C, Gabrysch A, Warnatz K, Goldacker S, Patiño V, Wolff D, Okada S, Hayakawa S, Shikama Y, Kanda K, Imai K, Sotomatsu M, Kuwashima M, Kamiya T, Morio T, Matsumoto K, Mori T, Yoshimoto Y, Dybedal I, Kanariou M, Kucuk ZY, Chapdelaine H, Petruzelkova L, Lorenz HM, Sullivan KE, Heimall J, Moutschen M, Litzman J, Recher M, Albert MH, Hauck F, Seneviratne S, Pachlopnik Schmid J, Kolios A, Unglik G, Klemann C, Snapper S, Giulino-Roth L, Svaton M, Platt CD, Hambleton S, Neth O, Gosse G, Reinsch S, Holzinger D, Kim YJ, Bakhtiar S, Atschekzei F, Schmidt R, Sogkas G, Chandrakasan S, Rae W, Derfalvi B, Marquart HV, Ozen A, Kiykim A, Karakoc-Aydiner E, Králíčková P, de Bree G, Kiritsi D, Seidel MG, Kobbe R, Dantzer J, Alsina L, Armangue T, Lougaris V, Agyeman P, Nyström S, Buchbinder D, Arkwright PD, Grimbacher B. Egg D, et al. Among authors: matsumoto k. J Allergy Clin Immunol. 2022 Feb;149(2):736-746. doi: 10.1016/j.jaci.2021.04.039. Epub 2021 Jun 7. J Allergy Clin Immunol. 2022. PMID: 34111452
Population-adjusted indirect treatment comparison of the SOLO1 and PAOLA-1/ENGOT-ov25 trials evaluating maintenance olaparib or bevacizumab or the combination of both in newly diagnosed, advanced BRCA-mutated ovarian cancer.
Vergote I, Ray-Coquard I, Anderson DM, Cantuaria G, Colombo N, Garnier-Tixidre C, Gilbert L, Harter P, Hettle R, Lorusso D, Mäenpää J, Marth C, Matsumoto K, Ouwens M, Poveda A, Raspagliesi F, Rhodes K, Rubio Pérez MJ, Shapira-Frommer R, Shikama A, Sikorska M, Moore K, DiSilvestro P. Vergote I, et al. Among authors: matsumoto k. Eur J Cancer. 2021 Nov;157:415-423. doi: 10.1016/j.ejca.2021.08.023. Epub 2021 Sep 28. Eur J Cancer. 2021. PMID: 34597975 Free article. Clinical Trial.
TISSUE CLEARING.
Richardson DS, Guan W, Matsumoto K, Pan C, Chung K, Ertürk A, Ueda HR, Lichtman JW. Richardson DS, et al. Among authors: matsumoto k. Nat Rev Methods Primers. 2021;1(1):84. doi: 10.1038/s43586-021-00080-9. Epub 2021 Dec 16. Nat Rev Methods Primers. 2021. PMID: 35128463 Free PMC article.
9,527 results